199 related articles for article (PubMed ID: 17766188)
1. The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): a suggestion.
Talwar GP; Ahmed N; Saini V
Infect Genet Evol; 2008 Jan; 8(1):100-1. PubMed ID: 17766188
[No Abstract] [Full Text] [Related]
2. Activation of complement by Mycobacterium leprae requires disruption of the bacilli.
Lahiri R; Sandoval FG; Krahenbuhl JL; Shannon EJ
Lepr Rev; 2008 Sep; 79(3):311-4. PubMed ID: 19009980
[TBL] [Abstract][Full Text] [Related]
3. Leprosy.
Rea TH; Modlin RL
Immunol Ser; 1989; 46():723-45. PubMed ID: 2488876
[No Abstract] [Full Text] [Related]
4. Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL).
Rada EM; Zambrano EA; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):222-5. PubMed ID: 16830648
[No Abstract] [Full Text] [Related]
5. Antibodies to phenolic glycolipid-I and sulfatide-I in leprosy and tuberculosis.
Luna-Herrera J; Arce-Paredes P; Rojas-Espinosa O
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):327-9. PubMed ID: 8862271
[No Abstract] [Full Text] [Related]
6. Cellular immune responses of healthy and Mycobacterium leprae-inoculated armadillos (Dasypus novemcinctus).
Rivero-Nava L; Quesada-Pascual F; Estrada-Garcia I; Estrada-Parra S; Santos-Argumedo L
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):485-7. PubMed ID: 10347570
[No Abstract] [Full Text] [Related]
7. Monoclonal antibodies and recombinant DNA technology: present and future uses in leprosy and tuberculosis.
Seckl MJ
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):618-40. PubMed ID: 3910750
[No Abstract] [Full Text] [Related]
8. Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions.
Zaheer SA; Misra RS; Sharma AK; Beena KR; Kar HK; Mukherjee A; Mukherjee R; Walia R; Talwar GP
Lepr Rev; 1993 Mar; 64(1):7-14. PubMed ID: 8464320
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to diverse lipids in the serum of patients with clinically cured leprosy and tuberculosis.
Rojas-Espinosa O; Arenas R; Arce-Parades P; Miranda-Contreras G
Acta Leprol; 2003; 12(3):112-6. PubMed ID: 15040701
[TBL] [Abstract][Full Text] [Related]
10. Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions.
Singh S; Jenner PJ; Narayan NP; Ramu G; Colston MJ; Prasad HK; Nath I
Infect Immun; 1994 Dec; 62(12):5702-5. PubMed ID: 7525491
[TBL] [Abstract][Full Text] [Related]
11. [Family management of leprosy].
García Martín J; Lasso Vázquez JM; Llovet Lombarte JM; Padín López F
Aten Primaria; 1995 Mar; 15(5):329-30. PubMed ID: 7734693
[No Abstract] [Full Text] [Related]
12. HLA-DQ molecules may be products of an immune suppression gene responsible for Mycobacterium leprae-specific nonresponsiveness.
Li SG; de Vries RR
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):554-6. PubMed ID: 2664049
[No Abstract] [Full Text] [Related]
13. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
[TBL] [Abstract][Full Text] [Related]
14. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
Bhargava P; Kuldeep CM; Mathur NK
Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
[No Abstract] [Full Text] [Related]
15. Towards new leprosy and tuberculosis vaccines.
Kaufmann S
Microbiol Sci; 1987 Nov; 4(11):324-8. PubMed ID: 3155274
[TBL] [Abstract][Full Text] [Related]
16. Treatment of leprosy: science or politics?
Naafs B
Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906
[TBL] [Abstract][Full Text] [Related]
17. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
18. Report of the Indo-European community joint symposium "Leprosy and other Mycobacterial Diseases," Lonavla, India, 6-9 November 1989.
Kaufmann SH; Deo MG
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):566-70. PubMed ID: 2119411
[No Abstract] [Full Text] [Related]
19. Pharmacologically-active mediators of hypersensitivity reactions in the blood of lepromatous patients with erythema nodosum leprosum.
Saha K; Lahiri SC
Lepr Rev; 1981 Dec; 52(4):315-20. PubMed ID: 7031390
[No Abstract] [Full Text] [Related]
20. Concomitant occurrence of leprosy and tuberculosis: leprosy vaccine, a myth or reality?
Seghal VN; Jain S
Lepr Rev; 1995 Jun; 66(2):179-81. PubMed ID: 7637529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
